|
|
(HealthNewsDigest.com) – ATLANTA – A goal of ophthalmology researchers is to deliver medication to the back of the eye in a selective and minimally invasive way. An Emory Eye Center scientist and two fellow researchers have investigated opportunities and have recently been awarded a U.S. patent for application of microneedle technology, designed to do just that.
Filed for in 2007 and awarded in April 2011, the patent (US 7,918,814) was awarded to Henry F. Edelhauser, Emory Eye Center’s former director of research, along with Mark Prausnitz, professor of chemical and biomedical engineering at the Georgia Institute of Technology, and Ninghao Jiang, a research graduate student at Georgia Tech, now employed at CNA, a non-profit research organization in Virginia.
Cutline: On left: in an enlarged photo, the tiny, new microneedle is drawfed by a currently-used intravitreal needle (above, right), itself a small needle (30 gauge).
Read more @ http://bit.ly/EmoryEyeCenterMicroneedlePatent
Check us out via social media: http://bit.ly/emoryhealthscisocial
###
Subscribe to our FREE Ezine and receive current Health News, be eligible for discounted products/services and coupons related to your Health. We publish 24/7.
HealthNewsDigest.com
For advertising/promotion, email: [email protected] Or call toll free: 877- 634-9180